T37.4X5D Adverse effect of anthelminthics, subsequent encounter

Name of the Condition

• Adverse effect of anthelminthics, subsequent encounter

Summary

This condition describes harmful or unintended reactions resulting from the use of anthelminthic medications during a subsequent encounter for care. It includes toxic effects, allergic responses, or other adverse events associated with these drugs, distinct from poisoning or underdosing scenarios. The "subsequent encounter" modifier indicates ongoing management or follow-up for the adverse effect.

Causes

Adverse effects can arise from allergic reactions, drug interactions, or individual sensitivity to anthelminthics. They may occur even when medications are administered correctly, as patient-specific factors or formulation issues can trigger unexpected responses. The subsequent encounter modifier applies when the patient is receiving ongoing care for the adverse effect.

Risk Factors

• Concurrent use of medications that interact with anthelminthics.
• Pre-existing renal or hepatic impairment affecting drug metabolism.
• History of hypersensitivity to anthelminthic or similar drug classes.
• Lack of proper medication monitoring or dosage adjustments.

Symptoms

• Nausea, vomiting, or gastrointestinal distress.
• Dizziness, confusion, or central nervous system effects.
• Skin rashes, itching, or hypersensitivity reactions.
• Signs of organ dysfunction (e.g., hepatic or renal).

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., renal/hepatic function, or parasitologic studies if infection is suspected). Documentation should clarify the ongoing nature of the adverse effect and the need for subsequent care.

Treatment Options

Management may include discontinuing the offending medication, supportive care (e.g., antiemetics, hydration), or alternative therapies. Treatment plans are tailored to the severity of symptoms and patient-specific factors.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Follow-up care ensures resolution of symptoms and monitoring for recurrence or complications. The subsequent encounter modifier reflects ongoing management.

Complications

Severe reactions may lead to organ damage, anaphylaxis, or treatment failure. Early recognition and intervention reduce the risk of long-term sequelae.

Lifestyle & Prevention

• Avoid known allergens or interacting medications.
• Follow prescribing instructions carefully.
• Report new symptoms promptly to healthcare providers.

When to Seek Professional Help

Seek care if symptoms worsen, new symptoms develop, or there are signs of organ dysfunction (e.g., jaundice, reduced urine output).

Tips for Medical Coders

Document the adverse effect and the reason for the subsequent encounter (e.g., follow-up, ongoing management). Ensure clinical notes support the use of the "subsequent encounter" modifier (D) and specify the anthelminthic involved.